DE

575.46

+2.76%↑

FDX

361.42

+2.8%↑

CTAS

172.22

+2.27%↑

HEICO

275.2

+0.61%↑

PAYX

90.46

-1.98%↓

DE

575.46

+2.76%↑

FDX

361.42

+2.8%↑

CTAS

172.22

+2.27%↑

HEICO

275.2

+0.61%↑

PAYX

90.46

-1.98%↓

DE

575.46

+2.76%↑

FDX

361.42

+2.8%↑

CTAS

172.22

+2.27%↑

HEICO

275.2

+0.61%↑

PAYX

90.46

-1.98%↓

DE

575.46

+2.76%↑

FDX

361.42

+2.8%↑

CTAS

172.22

+2.27%↑

HEICO

275.2

+0.61%↑

PAYX

90.46

-1.98%↓

DE

575.46

+2.76%↑

FDX

361.42

+2.8%↑

CTAS

172.22

+2.27%↑

HEICO

275.2

+0.61%↑

PAYX

90.46

-1.98%↓

Search

Avery Dennison Corp

Open

BrancheIndustrie

173.03 0.62

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

171.54

Max

176.23

Schlüsselkennzahlen

By Trading Economics

Einkommen

100K

166M

Verkäufe

56M

2.3B

KGV

Branchendurchschnitt

19.13

57.257

EPS

2.45

Dividendenrendite

2.21

Gewinnspanne

7.327

Angestellte

35,000

EBITDA

-107M

245M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+26.77% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.21%

2.27%

Nächstes Ergebnis

22. Apr. 2026

Nächste Dividendenausschüttung

17. Juni 2026

Nächstes Ex-Dividendendatum

3. Juni 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.5B

13B

Vorheriger Eröffnungskurs

172.41

Vorheriger Schlusskurs

173.03

Nachrichtenstimmung

By Acuity

53%

47%

343 / 405 Ranking in Industrials

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Avery Dennison Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

31. März 2026, 23:31 UTC

Heiße Aktien

Stocks to Watch: Nike, RH, NCino

31. März 2026, 22:35 UTC

Ergebnisse

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1. Apr. 2026, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31. März 2026, 23:50 UTC

Akquisitionen, Fusionen, Übernahmen

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31. März 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31. März 2026, 23:33 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31. März 2026, 23:21 UTC

Ergebnisse

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31. März 2026, 23:14 UTC

Market Talk
Ergebnisse

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31. März 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke 2025 Loss Widens >000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31. März 2026, 21:46 UTC

Akquisitionen, Fusionen, Übernahmen

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31. März 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31. März 2026, 21:35 UTC

Ergebnisse

Nike Expects China Sales Down 20% in 4Q, CFO Says

31. März 2026, 21:35 UTC

Ergebnisse

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31. März 2026, 21:35 UTC

Ergebnisse

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31. März 2026, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31. März 2026, 21:33 UTC

Ergebnisse

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31. März 2026, 21:32 UTC

Ergebnisse

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31. März 2026, 21:28 UTC

Ergebnisse

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31. März 2026, 21:26 UTC

Ergebnisse

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31. März 2026, 21:25 UTC

Ergebnisse

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31. März 2026, 21:24 UTC

Market Talk
Ergebnisse

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31. März 2026, 21:22 UTC

Ergebnisse

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31. März 2026, 21:22 UTC

Ergebnisse

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31. März 2026, 21:21 UTC

Ergebnisse

Nike's Digital Channel Still Too Promotional, CFO Says

31. März 2026, 21:20 UTC

Ergebnisse

Nike CEO: Converse Remains Important to Portfolio

Peer-Vergleich

Kursveränderung

Avery Dennison Corp Prognose

Kursziel

By TipRanks

26.77% Vorteil

12-Monats-Prognose

Durchschnitt 213.17 USD  26.77%

Hoch 233 USD

Tief 185 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avery Dennison Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

6 ratings

4

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

171.72 / 173.62Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

No Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

343 / 405 Ranking in Industrie

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Avery Dennison Corp

Avery Dennison Corporation operates as a materials science and digital identification solutions company in the United States, Europe, the Middle East, North Africa, Asia, Latin, America, and internationally. It provides pressure-sensitive materials comprising papers, plastic films, metal foils, and fabrics; performance tapes products, including tapes for wire harnessing, as well as cable wrapping for automotive, electrical, and general industrial applications; mechanical fasteners, which are precision-extruded and injection-molded plastic devices used in various automotive, general industrial, and retail applications; and other pressure-sensitive adhesive-based materials and converted products under the Fasson, JAC, Yongle, and Avery Dennison brands. The company also offers graphics and reflective products for the architectural, commercial sign, digital printing, and other related market segments; durable cast and reflective films to the construction, automotive, and fleet transportation market segments; reflective films for traffic and safety applications; and pressure-sensitive vinyl and specialty materials designed for digital imaging, screen printing, and sign cutting applications under the Avery Dennison and Mactac brand names. In addition, it provides branding solutions include brand embellishments, graphic tickets, tags, and labels, and sustainable packaging; and information solutions include item-level RFID, visibility and loss prevention, price ticketing and marking, productivity and media solutions, and brand protection and security solutions, as well as care, content, and country of origin compliance solutions. It serves home and personal care, apparel, e-commerce, logistics, food and grocery, pharmaceuticals, and automotive industries. The company was formerly known as Avery International Corporation and changed its name to Avery Dennison Corporation in 1990. Avery Dennison Corporation was founded in 1935 and is headquartered in Mentor, Ohio.
help-icon Live chat